Publication | Closed Access
Bioinformatic analysis of potential candidates for therapy of inflammatory bowel disease.
14
Citations
0
References
2015
Year
MAPK3, NDRG1 and HLA-DRA may play key roles in the progression and development of IBD. They may be used as specific therapeutic targets in the treatment of IBD. However, further experiments are still needed to confirm our results.